-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Esperion Therapeutics (ESPR)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Esperion Therapeutics (ESPR)
-
-
-
-
-
-
-
Esperion Announces Closing of $56.7 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Esperion to Participate in Upcoming H.C. Wainwright Global Investment Conference
-
-
-
-
-
-
-
Esperion Announces Proposed Public Offering
-
-
-
21,396 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

